Monopar Therapeutics Inc. (MNPR) Misses Q3 EPS by 27c
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Join SI Premium – FREE
Monopar Therapeutics Inc. (NASDAQ: MNPR) reported Q3 EPS of ($0.37), $0.27 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Monopar Therapeutics Inc. (MNPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- S&P announces major changes in S&P 100, S&P 500, S&P 400
- Colgate-Palmolive, Nike dropped from S&P 100
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
